2023
DOI: 10.1016/j.prp.2023.154497
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
29
0
6

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 52 publications
(36 citation statements)
references
References 433 publications
(472 reference statements)
1
29
0
6
Order By: Relevance
“…Dennoch gibt es Berichte über das Auftreten von mitunter auch neurologischen Symptomen, die im Zusammenhang mit einer Impfung gegen SARS-CoV-2 auftraten [88,89]. Die meisten der berichteten Symptome sind mild und nur von kurzer Dauer, wie Erschöpfung, Schmerzen an der Einstichstelle, Fieber, Schüttelfrost, Muskel-, Gelenk-und Kopfschmerzen [90,91].…”
Section: Prognoseunclassified
See 3 more Smart Citations
“…Dennoch gibt es Berichte über das Auftreten von mitunter auch neurologischen Symptomen, die im Zusammenhang mit einer Impfung gegen SARS-CoV-2 auftraten [88,89]. Die meisten der berichteten Symptome sind mild und nur von kurzer Dauer, wie Erschöpfung, Schmerzen an der Einstichstelle, Fieber, Schüttelfrost, Muskel-, Gelenk-und Kopfschmerzen [90,91].…”
Section: Prognoseunclassified
“…In etwa 1% der Fälle schienen diese Symptome länger als einen Monat anzuhalten [92]. Das klinische Bild dieser anhaltenden Beschwerden ist allerdings heterogen und überschneidet sich teilweise mit dem des Post-CO-VID-19-Syndroms [91]. So wird in beiden Fällen von einer Fatigue-Symptomatik, kognitiven Defiziten und Kopfschmerzen berichtet [91].…”
Section: Merkeunclassified
See 2 more Smart Citations
“…Coronavirus disease 2019 (COVID-19) is a complex disorder caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and affects many bodily functions, including excessive immunological response, autoimmunity, and endothelial dysfunction, that have been implicated in the risk of thrombotic events and coagulopathies. While the acute phase of COVID-19 primarily manifests as a respiratory illness, with a wide range of symptoms including fever, headache, cough, fatigue, muscle pain, and shortness of breath, more severe clinical symptoms, such as systemic inflammatory response syndrome (SIRS), acute respiratory disease syndrome (ARDS), and neurological and cardiovascular complications, have been associated with processes underlying coagulopathies and endotheliopathies. ,, Currently, it is estimated that approximately 30% of individuals with COVID-19 continue to suffer from a variety of different symptoms involving specific or multiple organ systems, with neurological, neuropsychiatric, and cardiorespiratory clinical presentations, , a condition known as postacute sequelae of COVID (PASC) or long COVID. ,, Fatigue, cough, dyspnea, chest pain, headache, dizziness, cognitive impairment known as “brain fog”, and long-term smell and taste dysfunction are the most commonly reported symptoms in individuals suffering from long COVID. ,, The World Health Organization defines long COVID as a condition in which individuals with a probable or confirmed infection with SARS-CoV-2 still experience COVID-19-related symptoms usually three months postinfection and lasting for at least two months, with no alternative diagnosis . Endotheliopathy, coagulopathy, and thrombosis are also now established complications of COVID-19 and can persist in individuals diagnosed with long COVID, contributing to the pathogenesis and clinical manifestations of these conditions. , …”
Section: Introductionmentioning
confidence: 99%